The 340B Drug Pricing Program plays an important role in the U.S. healthcare system, connecting questions of drug pricing, patient access, compliance, and pharmaceutical manufacturer economics.
The new 340 B Drug Pricing Program SoundBite helps life sciences professionals build a foundational understanding of the program, how it works, and its impact across the industry.
What Is the 340B Drug Pricing Program?
The 340B Drug Pricing Program is a federal initiative that allows eligible hospitals and clinics to purchase outpatient drugs at significant discounts, helping these organizations stretch their resources to support low-income patients.
Since its creation, the program has expanded considerably. That growth has brought a broader network of stakeholders, participation requirements, compliance considerations, and financial implications for the pharmaceutical industry.
The new SoundBite explores:
- How the 340B Drug Pricing Program originated and expanded
- The roles of covered entities, HRSA, and contract pharmacies
- Eligibility requirements for participating in the program
- Key compliance risks, including drug diversion and duplicate discounts
- The financial impact of 340B on pharmaceutical manufacturers
Why Understanding 340B Matters
For life sciences professionals, 340B is more than a drug discount program. Its structure and growth have implications for how eligible healthcare organizations purchase outpatient drugs and how pharmaceutical manufacturers navigate discounts and program requirements.
For L&D leaders, building foundational knowledge of programs like 340B can help teams better understand the healthcare market in which their customers operate. Understanding who participates, how eligibility is determined, and where compliance risks can arise gives learners important context for more informed customer and market conversations.
Learn on the Go With CMR SoundBites
CMR SoundBites are short-form audio learning resources designed to make important healthcare and life sciences topics easier to learn wherever you are.
Each SoundBite focuses on a specific topic, giving learners an accessible way to build or refresh their knowledge without committing to a longer learning experience.
The 340B Drug Pricing Program SoundBite provides a focused introduction to a program with significant implications for healthcare organizations and pharmaceutical manufacturers.
Add this new SoundBite to your training program and help strengthen your team’s understanding of the 340B Drug Pricing Program.
